Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dharmendra Kumar Yadav

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Journal of Molecular Modeling|January 25, 2012
Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activityKomal Kalani, Dharmendra Kumar Yadav, Feroz Khan, et al.
Molecular Biology Reports|October 28, 2025
Molecular crosstalk between miRNAs and lncRNAs in neurodegenerative disease pathwaysFalguni Goel, Daksh Kumar, Payal Singh, et al.
Scientific Reports|August 7, 2025
Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulationsMohd Shahnawaz Khan, Anas Shamsi, Moyad Shahwan, et al.
The Journal of Chemical Physics|November 3, 2023
Temperature dependent charge carrier dynamics in 2D ternary Cu2MoS4 nanoflakes: An effect of electron-phonon couplingTanmay Goswami, Dharmendra Kumar Yadav, Himanshu Bhatt, et al.
ACS Omega|December 18, 2023
Experimental and Computational Insights into the Molecular Interactions between Human Transferrin and Apigenin: Implications of Natural Compounds in Targeting NeuroinflammationMoyad Shahwan, Saleha Anwar, Dharmendra Kumar Yadav, et al.
Journal of Alzheimer'S Disease : JAD|June 14, 2024
Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's DiseaseAnas Shamsi, Mohammad Furkan, Mohd Shahnawaz Khan, et al.
Molecular Biology Reports|July 25, 2025
Evidence based molecular pathways, available drug targets, pre- clinical animal models and future disease modifying treatments of huntington's diseaseFalguni Goel, Vaishali Dobhal, Daksh Kumar, et al.
Heliyon|July 19, 2024
Computational and spectroscopic insight into the binding of citral with human transferrin: Targeting neurodegenerative diseasesAnas Shamsi, Moyad Shahwan, Mohammad Furkan, et al.
Frontiers in Immunology|December 25, 2024
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancerDesh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Scientific Reports|March 16, 2019
Molecular dynamic simulations of oxidized skin lipid bilayer and permeability of reactive oxygen speciesDharmendra Kumar Yadav, Surendra Kumar, Eun-Ha Choi, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Journal of Molecular Modeling|January 25, 2012
Pharmacophore, QSAR, and ADME based semisynthesis and in vitro evaluation of ursolic acid analogs for anticancer activityKomal Kalani, Dharmendra Kumar Yadav, Feroz Khan, et al.
Molecular Biology Reports|October 28, 2025
Molecular crosstalk between miRNAs and lncRNAs in neurodegenerative disease pathwaysFalguni Goel, Daksh Kumar, Payal Singh, et al.
Scientific Reports|August 7, 2025
Targeting programmed death ligand 1 for anticancer therapy using computational drug repurposing and molecular simulationsMohd Shahnawaz Khan, Anas Shamsi, Moyad Shahwan, et al.
The Journal of Chemical Physics|November 3, 2023
Temperature dependent charge carrier dynamics in 2D ternary Cu2MoS4 nanoflakes: An effect of electron-phonon couplingTanmay Goswami, Dharmendra Kumar Yadav, Himanshu Bhatt, et al.
ACS Omega|December 18, 2023
Experimental and Computational Insights into the Molecular Interactions between Human Transferrin and Apigenin: Implications of Natural Compounds in Targeting NeuroinflammationMoyad Shahwan, Saleha Anwar, Dharmendra Kumar Yadav, et al.
Journal of Alzheimer'S Disease : JAD|June 14, 2024
Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer's DiseaseAnas Shamsi, Mohammad Furkan, Mohd Shahnawaz Khan, et al.
Molecular Biology Reports|July 25, 2025
Evidence based molecular pathways, available drug targets, pre- clinical animal models and future disease modifying treatments of huntington's diseaseFalguni Goel, Vaishali Dobhal, Daksh Kumar, et al.
Heliyon|July 19, 2024
Computational and spectroscopic insight into the binding of citral with human transferrin: Targeting neurodegenerative diseasesAnas Shamsi, Moyad Shahwan, Mohammad Furkan, et al.
Frontiers in Immunology|December 25, 2024
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancerDesh Deepak Singh, Shafiul Haque, Youngsun Kim, et al.
Scientific Reports|March 16, 2019
Molecular dynamic simulations of oxidized skin lipid bilayer and permeability of reactive oxygen speciesDharmendra Kumar Yadav, Surendra Kumar, Eun-Ha Choi, et al.
Pageof 14